A new type of cancer drug delivery system has been developed by a group of investigators from Yale University. The therapy delivers a dose of immune-system booster and a chemical to counter chemical secretions of cancer cells simultaneously. The new approach has been published in the scientific journal, Nature Materials.
Small structures called nanolipogels (NLG) form the backbone of the new technique. The nanolipogels are fitted with two types of chemicals, one inhibitor drug that is antagonistic to transforming growth factor-β, second molecule included in the nanolipogels are interleukin-2. The inhibitor and interleukin stops tumor growth and promotes remission in mice.
The graphic accompanying the article, is brilliant and I could not but put it up for CureTalk readers. While here do check out the webcast explaining the novel drug delivery system.
- New Drug Delivery System Developed for Parkinson’s Disease [Video]
- Bristol Myers Squibb Cancer Drug Blocks PD1 Protein And Helps Immune System Fight Cancer
- Good news for Diabetics — Artifical Insulin Delivery System Awaiting Entry Into Clinical Trials
- Off-Label Drug Use In Cancer
- Diamyd’s Virus-Based Nerve Targeting Pain Control System For Cancer Patients